Use of aspirin in secondary prevention of coronary heart disease is rising

BMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7034.846 (Published 30 March 1996) Cite this as: BMJ 1996;312:846
  1. A J Carney,
  2. T A Carney
  1. Medical student Addenbrooke's Hospital, Cambridge CB2 2QQ
  2. General practitioner Burn Brae Medical Group, Hexham, Northumberland NE46 2ED

    EDITOR,—We can confirm Ray King and Jonathan Denne's findings of an increased use of low dose aspirin in secondary prevention of cardiovascular disease1 and have a suggestion for why there may be a difference in the prevalence of such treatment between the sexes and how this might be overcome.

    Throughout 1994 and 1995 the Burn Brae Medical Group, a practice of six partners with 8200 patients in a market town, carried out three audits of the subject. A computer search followed …

    View Full Text

    Sign in

    Log in through your institution